tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
NEUP
Neuphoria Therapeutics
RESEARCH TOOLSreports
Want to see NEUP full AI Analyst Report?

Neuphoria Therapeutics (NEUP) Revenue

300 Followers
StatisticsMarket CapRevenue

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2026, with ―. This bring the company's revenue in the last twelve months to -10.47M, Increased -331.30%. In the fiscal year ending Jun 30, 2025, Neuphoria Therapeutics had annual revenue of 15.65M with Infinity% growth.
Revenue (ttm)
-10.47M
Revenue Growth
―
P/S Ratio
1.22
Revenue/Employee
$1,956,181
Employees
8
Market Cap
$19.08M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2025
15.65M―+∞%
Jun 30, 2024
―――
Jun 30, 2023
―-383.16K-100.00%
Jun 30, 2022
383.16K-544.39K-58.69%
Jun 30, 2021
927.54K895.48K+2,792.97%
Jun 30, 2020
32.06K-7.36M-99.57%
Jun 30, 2019
7.40M-4.55M-38.08%
Jun 30, 2018
11.94M-15.20M-56.00%
Jun 30, 2017
27.15M――